Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -3.58x is 78% above its 5-year average of -16.37x, near the high end of its 5-year range (-124.80x–48.25x).
11.60% above its 12-month average of -4.05x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 3.76x.
INTEREST COVERAGE RATIO
-3.58x
INTEREST COVERAGE RATIO AVG TTM
-4.05x
INTEREST COVERAGE RATIO AVG 3Y
-23.62x
INTEREST COVERAGE RATIO AVG 5Y
-16.37x
INTEREST COVERAGE RATIO AVG 10Y
-21.26x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+11.60%
CURRENT VS 3Y AVG
+84.84%
CURRENT VS 5Y AVG
+78.13%
CURRENT VS 10Y AVG
+83.16%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
+44.41%
vs the sector median at left
REGENXBIO Inc.
Market Cap
$385.15M
Interest Coverage Ratio
-3.58x
TTM Avg
-4.05x
3Y Avg
-23.62x
5Y Avg
-16.37x
Market Cap
$380.37M
Interest Coverage Ratio
-3.92x
TTM Avg
67.22x
3Y Avg
51.13x
5Y Avg
40.74x
Market Cap
$376.01M
Interest Coverage Ratio
-1.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$374.50M
Interest Coverage Ratio
-347.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$396.93M
Interest Coverage Ratio
-375.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$397.99M
Interest Coverage Ratio
-21.38x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$369.50M
Interest Coverage Ratio
N/A
TTM Avg
4.06x
3Y Avg
4.06x
5Y Avg
4.06x
Market Cap
$402.17M
Interest Coverage Ratio
-20641.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| REGENXBIO Inc. (RGNX) | $385.15M | -3.58x | -4.05x | -23.62x | -16.37x |
| Orthofix Medical Inc. (OFIX)vs › | $380.37M | -3.92x | 67.22x | 51.13x | 40.74x |
| Zura Bio Limited (ZURA)vs › | $376.19M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $376.01M | -1.91x | N/A | N/A | N/A |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $374.50M | -347.29x | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | -375.67x | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $397.99M | -21.38x | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $369.50M | N/A | 4.06x | 4.06x | 4.06x |
| Neurogene Inc. (NGNE)vs › | $402.17M | -20641.60x | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | -6.46x | 19.36x | 139.34x | 245.68x |
Interest Coverage
-3.6x
Debt/Equity
0.96
Current Ratio
2.86
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 3.76x |
| 2026-03-31 | -9.57x |
| 2025-12-31 | -4.70x |
| 2025-09-30 | -3.98x |
| 2025-06-30 | -5.76x |
| 2025-03-31 | 1.42x |
| 2024-12-31 | -5.45x |
| 2024-09-30 | -75.70x |
| 2024-06-30 | -124.80x |
| 2024-03-31 | -31.30x |
| 2023-12-31 | -46.88x |
| 2023-09-30 | -40.00x |
| 2023-06-30 | -65.28x |
| 2023-03-31 | -24.01x |
| 2022-12-31 | -13.40x |
| 2022-09-30 | -11.93x |
| 2022-06-30 | -9.12x |
| 2022-03-31 | -11.67x |
| 2021-12-31 | 48.25x |
| 2021-09-30 | -8.55x |
| 2021-06-30 | -8.20x |
| 2021-03-31 | -6.57x |
| 2020-12-31 | -69.59x |
| 2015-03-31 | -199.65x |
| 2014-12-31 | -18.63x |
| 2014-09-30 | -18.49x |
